Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
HSDD is estimated to affect about 10% of women in the United States, according to a 2022 review in CNS Spectrums , and Vyleesi is one of only two FDA-approved therapies specifically indicated for female sexual desire
mSphere 2 , e00351-17 (2017)
This article will break down each medication and explain the differences between the two so you can better weigh your options
Willing to follow nutrition guidance and hydration goals
Losing just 5-10% of your body weight is shown to significantly improve OSA symptoms like snoring, gasping for air, and for some, healthy sustained weight loss may even resolve the condition
Sources: Wessells H, et al
US$ 20.57
US$ 23.36
US$ 29.07
US$ 20.71
US$ 25.64
US$ 29.08
US$ 29.53
US$ 20.76
US$ 20.53
